DrugPatentWatch Database Preview
CEFTIN Drug Profile
When do Ceftin patents expire, and what generic alternatives are available?
The generic ingredient in CEFTIN is cefuroxime axetil. There are sixty-one drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.
Summary for CEFTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 20 |
| Patent Applications: | 1,628 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | CEFTIN at DailyMed |
Pharmacology for CEFTIN
| Ingredient-type | Cephalosporins |
| Drug Class | Cephalosporin Antibacterial |
Synonyms for CEFTIN
| (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-acetyloxyethyl ester |
| (6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-(Acetyloxy)ethyl Ester |
| (RS)-1-Hydroxyethyl (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), 1-acetate 3-carbamate |
| 1-acetoxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| 1-acetyloxyethyl (6R,7R)-3-(aminocarbonyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| 1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, 1-(acetyloxy)ethyl ester, (6R-(6alpha,7beta(Z)))- |
| 544C076 |
| 64544-07-6 |
| A834806 |
| AC1O426M |
| AKOS015896220 |
| Altacef |
| AN-38773 |
| anti-Cefloxime axetil |
| AT-20730 |
| Bioracef |
| BRN 6854419 |
| C08107 |
| C20H22N4O10S |
| CCG-221241 |
| CCI 1564 |
| CCI 15641 |
| CCI-15641 |
| Cefaks |
| Cefazine |
| Cefuroximaxetil |
| Cefuroxime 1-acetoxyethyl ester |
| cefuroxime axetil |
| Cefuroxime axetil (JP17/USP/INN) |
| Cefuroxime axetil [USAN:BAN:JAN] |
| Cefuroxime axetil [USAN:USP:BAN:JAN] |
| Cefuroxime Axetil, European Pharmacopoeia (EP) Reference Standard |
| Cefuroxime Axetil, mixture of isomers, analytical standard |
| Cefuroxime Axetil, United States Pharmacopeia (USP) Reference Standard |
| Celocid |
| Cepazine |
| Cethixim |
| Cetoxil |
| CHEBI:3516 |
| CHEMBL1095930 |
| Coliofossim |
| CXM-AX |
| D00914 |
| DRG-0157 |
| Elobact |
| Forcef |
| Furoxime |
| HSDB 8150 |
| I06-1564 |
| Kalcef |
| LS-149935 |
| Maxitil |
| Medoxm |
| MolPort-005-935-571 |
| Nivador |
| SCHEMBL721709 |
| Sharox-500 |
| SN 407 |
| SN-407 |
| ST51053128 |
| Zinat |
| Zinnat |
| Zoref |
US Patents and Regulatory Information for CEFTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | CEFTIN | cefuroxime axetil | FOR SUSPENSION;ORAL | 050672-001 | Jun 30, 1994 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Glaxosmithkline | CEFTIN | cefuroxime axetil | TABLET;ORAL | 050605-002 | Dec 28, 1987 | AB | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Glaxosmithkline | CEFTIN | cefuroxime axetil | FOR SUSPENSION;ORAL | 050672-002 | Apr 29, 1997 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Glaxosmithkline | CEFTIN | cefuroxime axetil | TABLET;ORAL | 050605-001 | Dec 28, 1987 | AB | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
